[Attention deficit disorder and hyperactivity: does the treatment affect the statural growth?].
The current study evaluated the influence of stimulant drugs used for attention deficit and hyperactivity (ADH) on statural growth. The authors conducted a literature review collecting published articles on attention deficit hyperactivity disorder and its relationship with short stature. The source of information was the PubMed database where the following terms were researched: "Growth and Methylphenidate"/"Attention deficit and hyperactivity versus short stature"/"Methylphenidate and growth disorders". ADH are difficult clinical situations that interfere with the patient's well-being and social and school performance. Once the diagnosis is attained stimulant medications such as methylphenidate have a key role in the treatment but there are concerns regarding their interference in growth and weight gain. We reviewed many publications regarding these side effects and there is no consensus on them; however, even when they happen to occur their intensity is not sufficient to preclude the use of the medication. We have to take into consideration the cost/benefit relationship, remembering that improvement in school and social performance are very welcome to the child and family. Careful monitoring of the growth chart can detect worsening of growth and its intensity will determine if the drug shall or shall not be interrupted.
Instituto da Criança, Hospital das Clínicas, FMUSP, São Paulo, SP, Brasil. durvald@iconet.com.br <durvald@iconet.com.br>
Durval
D
Damiani
Daniel
D
Damiani
Erasmo
E
Casella
D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D003362:Cost-Benefit Analysis; D006128:Growth / Q000187:drug effects*; D006801:Humans; D008774:Methylphenidate / Q000009:adverse effects*
D000697:Central Nervous System Stimulants; D008774:Methylphenidate